DK3061456T3 - Process for metabolic control and high solute clearance and solutions for use therein - Google Patents
Process for metabolic control and high solute clearance and solutions for use therein Download PDFInfo
- Publication number
- DK3061456T3 DK3061456T3 DK15173139.5T DK15173139T DK3061456T3 DK 3061456 T3 DK3061456 T3 DK 3061456T3 DK 15173139 T DK15173139 T DK 15173139T DK 3061456 T3 DK3061456 T3 DK 3061456T3
- Authority
- DK
- Denmark
- Prior art keywords
- solutions
- metabolic control
- high solute
- solute clearance
- clearance
- Prior art date
Links
- 230000002503 metabolic effect Effects 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/14—Alkali metal chlorides; Alkaline earth metal chlorides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/08—Plasma substitutes; Perfusion solutions; Dialytics or haemodialytics; Drugs for electrolytic or acid-base disorders, e.g. hypovolemic shock
Landscapes
- Health & Medical Sciences (AREA)
- Public Health (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Inorganic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- Urology & Nephrology (AREA)
- External Artificial Organs (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US11/273,290 US7884132B2 (en) | 2005-11-14 | 2005-11-14 | Process for metabolic control and high solute clearance and solutions for use therein |
| EP06837587.2A EP1948205B1 (en) | 2005-11-14 | 2006-11-14 | Process for metabolic control and high solute clearance and solutions for use therein |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK3061456T3 true DK3061456T3 (en) | 2022-05-09 |
Family
ID=38041129
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK06837587.2T DK1948205T3 (da) | 2005-11-14 | 2006-11-14 | Proces til metabolisk styring og high-solute-clearance samt opløsninger til anvendelse deri |
| DK15173139.5T DK3061456T3 (en) | 2005-11-14 | 2006-11-14 | Process for metabolic control and high solute clearance and solutions for use therein |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK06837587.2T DK1948205T3 (da) | 2005-11-14 | 2006-11-14 | Proces til metabolisk styring og high-solute-clearance samt opløsninger til anvendelse deri |
Country Status (10)
| Country | Link |
|---|---|
| US (2) | US7884132B2 (da) |
| EP (2) | EP3061456B1 (da) |
| JP (1) | JP2009523117A (da) |
| AU (1) | AU2006315455B2 (da) |
| CA (1) | CA2632157C (da) |
| DK (2) | DK1948205T3 (da) |
| ES (2) | ES2547607T3 (da) |
| PL (1) | PL1948205T3 (da) |
| PT (2) | PT3061456T (da) |
| WO (1) | WO2007059145A2 (da) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8133194B2 (en) * | 2006-02-22 | 2012-03-13 | Henry Ford Health System | System and method for delivery of regional citrate anticoagulation to extracorporeal blood circuits |
| US8211048B2 (en) * | 2006-02-22 | 2012-07-03 | Henry Ford Health System | System and method for delivery of regional citrate anticoagulation to extracorporeal blood circuits |
| US9603989B2 (en) | 2010-08-24 | 2017-03-28 | Fenwal, Inc. | Methods for anticoagulating blood |
| EP2991640B1 (en) | 2013-04-30 | 2018-12-05 | Gambro Lundia AB | A multipart fluid system and a system for citrate anticoagualation in an extracorporeal blood circuit |
| US10420797B2 (en) | 2013-04-30 | 2019-09-24 | Gambro Lundia Ab | Anticoagulation fluid comprising citrate and phosphate |
| CN105517490B (zh) * | 2015-09-15 | 2018-08-10 | 薛迎风 | 全自动枸橼酸局部抗凝机 |
| EP3684436B1 (en) | 2017-09-22 | 2024-11-27 | Becton, Dickinson and Company | 4% trisodium citrate solution for use as a catheter lock solution |
| WO2020132389A1 (en) * | 2018-12-20 | 2020-06-25 | University Of Maryland, Baltimore | Hemofiltration device, system and method for a high blood flow extracorporeal circuit |
| US11007310B2 (en) | 2018-12-28 | 2021-05-18 | Fresenius Medical Care Holdings, Inc. | Systems and methods for estimating ultrafiltration rates |
| WO2022150631A1 (en) * | 2021-01-08 | 2022-07-14 | Hdl Therapeutics, Inc | Systems and methods for reducing low attenuation plaque and/or plaque burden in patients |
| WO2023150217A1 (en) * | 2022-02-02 | 2023-08-10 | University Of Pittsburgh - Of The Commonwealth System Of Higher Education | Restrictive versus liberal rate of extracorporeal volume removal evaluation in acute kidney injury |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4500309A (en) * | 1982-05-07 | 1985-02-19 | The Kansas University Endowment Association | Method for regional anticoagulation during extracorporeal dialysis |
| US5032615A (en) * | 1989-10-31 | 1991-07-16 | The Regents Of The University Of California | Continuous hemodialysis using citrate |
| DE4114908A1 (de) * | 1991-05-07 | 1992-11-12 | Klaus Dr Med Sodemann | Dialyseloesung zur dialysebehandlung, konzentrat und vorrichtung zur dialysebehandlung |
| JPH115334A (ja) * | 1997-04-23 | 1999-01-12 | Canon Inc | 印刷装置及びその制御方法及び前記印刷装置を接続する情報処理装置及びシステム及び記憶媒体 |
| US7670491B2 (en) * | 1998-10-20 | 2010-03-02 | Advanced Renal Technologies | Buffered compositions for dialysis |
| ATE405277T1 (de) * | 1999-04-26 | 2008-09-15 | Edwards Lifesciences Ag | Substitutions-infusionflüssigkeit und zitratanticoagulation |
| US7186420B2 (en) * | 1999-04-26 | 2007-03-06 | Edwards Lifesciences Corporation | Multi-part substitution infusion fluids and matching anticoagulants |
| WO2001089513A1 (en) * | 2000-05-24 | 2001-11-29 | Uab Research Foundation | Use of citrate-containing dialysate for renal dialysis treatment |
| CA2365787C (en) * | 2000-12-20 | 2006-02-14 | Dialysis Solutions Inc. | Sterile low bicarbonate dialysis concentrate solutions |
| DE10114283C2 (de) * | 2000-12-22 | 2003-04-24 | Fresenius Medical Care De Gmbh | Verfahren zur Ermittlung der Ionenkonzentration des Blutes eines Patienten bei der citrat-antikoagulierten Hämodialyse und/oder Hämofiltration; Dialysegerät |
| JP4647953B2 (ja) * | 2003-12-26 | 2011-03-09 | マナック株式会社 | 一剤型重炭酸透析用固形剤及びその製造方法 |
| US7544301B2 (en) * | 2004-08-19 | 2009-06-09 | Hhd Llc | Citrate-based dialysate chemical formulations |
-
2005
- 2005-11-14 US US11/273,290 patent/US7884132B2/en active Active
-
2006
- 2006-11-14 WO PCT/US2006/044219 patent/WO2007059145A2/en not_active Ceased
- 2006-11-14 JP JP2008540281A patent/JP2009523117A/ja not_active Withdrawn
- 2006-11-14 AU AU2006315455A patent/AU2006315455B2/en active Active
- 2006-11-14 EP EP15173139.5A patent/EP3061456B1/en active Active
- 2006-11-14 EP EP06837587.2A patent/EP1948205B1/en active Active
- 2006-11-14 ES ES06837587.2T patent/ES2547607T3/es active Active
- 2006-11-14 CA CA2632157A patent/CA2632157C/en active Active
- 2006-11-14 ES ES15173139T patent/ES2832023T3/es active Active
- 2006-11-14 PT PT151731395T patent/PT3061456T/pt unknown
- 2006-11-14 PL PL06837587T patent/PL1948205T3/pl unknown
- 2006-11-14 PT PT68375872T patent/PT1948205E/pt unknown
- 2006-11-14 DK DK06837587.2T patent/DK1948205T3/da active
- 2006-11-14 DK DK15173139.5T patent/DK3061456T3/da active
-
2011
- 2011-01-20 US US13/010,770 patent/US8147698B2/en not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| EP3061456B1 (en) | 2020-07-22 |
| WO2007059145A3 (en) | 2009-05-07 |
| US8147698B2 (en) | 2012-04-03 |
| EP1948205A2 (en) | 2008-07-30 |
| CA2632157A1 (en) | 2007-05-24 |
| US20110230813A1 (en) | 2011-09-22 |
| ES2547607T3 (es) | 2015-10-07 |
| ES2832023T3 (es) | 2021-06-09 |
| EP3061456A3 (en) | 2016-11-30 |
| AU2006315455A1 (en) | 2007-05-24 |
| WO2007059145A2 (en) | 2007-05-24 |
| DK1948205T3 (da) | 2015-08-24 |
| EP1948205A4 (en) | 2010-03-10 |
| WO2007059145A9 (en) | 2009-07-16 |
| PT3061456T (pt) | 2020-11-20 |
| PT1948205E (pt) | 2015-10-16 |
| EP1948205B1 (en) | 2015-06-24 |
| CA2632157C (en) | 2016-01-12 |
| US20070110829A1 (en) | 2007-05-17 |
| US7884132B2 (en) | 2011-02-08 |
| EP3061456A2 (en) | 2016-08-31 |
| AU2006315455B2 (en) | 2012-07-05 |
| PL1948205T3 (pl) | 2015-12-31 |
| JP2009523117A (ja) | 2009-06-18 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ZA200710713B (en) | Methods for preventing and treating metabolic disorders and new pyrazole-o-glycoside derivatives | |
| GB2434604B (en) | Porous composites containing hydrocarbon-soluble well treatment agents and methods for using the same | |
| EP1958033A4 (en) | CONTROL UNIT FOR UTILITY TREATMENT SYSTEMS | |
| ZA200804673B (en) | Nuclear reprogramming factor | |
| IL190622A0 (en) | Polyaxial screw | |
| IL183740A0 (en) | Cyclohexylamides as dopamine d3, d2 and | |
| IL183889A0 (en) | Treatment method | |
| ZA200802064B (en) | Method for the treatment of acne | |
| EP1958177A4 (en) | PERFUSION PROCESS AND DEVICE | |
| EP1949939A4 (en) | PRESSURE DRIVE APPARATUS AND METHOD FOR CONTROLLING THE SAME | |
| DK3061456T3 (en) | Process for metabolic control and high solute clearance and solutions for use therein | |
| EP1909474A4 (en) | IMAGE PROCESSOR AND METHOD FOR CONTROLLING THE SAME | |
| IL180446A0 (en) | Object process graph application controller-viewer | |
| EP1912222A4 (en) | MEMORY CONTROL METHOD AND STORAGE SYSTEM | |
| GB0522939D0 (en) | Shared classes cache computer system and method therefor | |
| TWI371932B (en) | Shared processor architecture and method thereof | |
| GB2430428B (en) | Device and method for the metering of solutions | |
| EP1951197A4 (en) | METHOD OF CHECKING THE PARTICLE SIZE | |
| GB0515138D0 (en) | Acne treatment | |
| TWI346671B (en) | Chemical composition and process | |
| GB0513489D0 (en) | Improvements in or relating to control apparatus | |
| GB0523713D0 (en) | Enclosure method | |
| GB0519047D0 (en) | Applicator, kit, and process | |
| EP2012539A4 (en) | SYSTEM, METHOD AND PROGRAM FOR STORING MOBILE IMAGES | |
| EP1873678A4 (en) | ACCESS RIGHTS ASSESSMENT SYSTEM, ACCESS RIGHTS ASSESSMENT PROCEDURE AND ACCESS RIGHTS ASSESSMENT PROGRAM |